Richard William Scalzo's most recent trade in Dyne Therapeutics Inc was a trade of 1,343 Common Stock done at an average price of $11.4 . Disclosure was reported to the exchange on March 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 11.38 per share. | 11 Mar 2025 | 1,343 | 122,330 | - | 11.4 | 15,283 | Common Stock |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 11.83 per share. | 05 Mar 2025 | 917 | 123,673 | - | 11.8 | 10,848 | Common Stock |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | Sale of securities on an exchange or to another person at price $ 13.95 per share. | 18 Feb 2025 | 2,488 | 124,590 | - | 14.0 | 34,708 | Common Stock |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 11 Dec 2024 | 1,455 | 127,078 | - | 28.1 | 40,915 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 04 Dec 2024 | 52,300 | 52,300 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 04 Dec 2024 | 32,700 | 128,533 | - | 0 | Common Stock | ||
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 18 Nov 2024 | 2,735 | 95,833 | - | 28.2 | 77,127 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 18 Sep 2024 | 1,390 | 98,568 | - | 34.6 | 48,025 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 11 Sep 2024 | 1,468 | 99,958 | - | 31.9 | 46,815 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 124,374 | 103,126 | - | 32.1 | 3,997,380 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 34,833 | 742 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 34,833 | 155,710 | - | 19 | 661,827 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 29,792 | 25,208 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 29,792 | 202,198 | - | 8.6 | 255,615 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 18,750 | 26,250 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 18,750 | 220,948 | - | 10.7 | 201,000 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 16,696 | 8,348 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 16,696 | 172,406 | - | 13.1 | 219,052 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 6,552 | 227,500 | - | 10.9 | 71,286 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 6,552 | 28,394 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 6,502 | 117,524 | - | 5.5 | 36,021 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 6,502 | 0 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 3,353 | 0 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 3,353 | 120,877 | - | 5.5 | 18,576 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 06 Sep 2024 | 1,700 | 101,426 | - | 32.6 | 55,471 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 19 Aug 2024 | 2,442 | 111,332 | - | 45.0 | 109,914 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 19 Aug 2024 | 310 | 111,022 | - | 46 | 14,260 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 10 Jun 2024 | 1,590 | 115,105 | - | 30.2 | 48,066 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 10 Jun 2024 | 1,331 | 113,774 | - | 31.3 | 41,714 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 16 May 2024 | 2,126 | 117,157 | - | 28.2 | 59,953 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 16 May 2024 | 462 | 116,695 | - | 28.6 | 13,209 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 08 Mar 2024 | 68,919 | 190,874 | - | 5.5 | 381,811 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 08 Mar 2024 | 68,919 | 9,855 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 08 Mar 2024 | 55,208 | 122,244 | - | 26.7 | 1,475,158 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 08 Mar 2024 | 30,755 | 177,452 | - | 25.3 | 778,409 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 08 Mar 2024 | 17,333 | 208,207 | - | 5.5 | 96,025 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 08 Mar 2024 | 17,333 | 0 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 08 Mar 2024 | 1,590 | 119,283 | - | 25.0 | 39,734 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 08 Mar 2024 | 1,082 | 120,873 | - | 25.7 | 27,807 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 08 Mar 2024 | 289 | 121,955 | - | 27.3 | 7,898 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 07 Mar 2024 | 2,273 | 121,955 | - | 25.8 | 58,757 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 29 Feb 2024 | 9,311 | 0 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 29 Feb 2024 | 9,311 | 133,539 | - | 1.0 | 9,590 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 29 Feb 2024 | 8,747 | 124,792 | - | 28.2 | 246,840 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 29 Feb 2024 | 3,429 | 124,228 | - | 27.5 | 94,298 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 29 Feb 2024 | 3,429 | 9,311 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 29 Feb 2024 | 3,429 | 127,657 | - | 1.0 | 3,532 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 29 Feb 2024 | 564 | 124,228 | - | 28.7 | 16,159 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 26 Jan 2024 | 13,000 | 124,228 | - | 24.3 | 316,420 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | SVP, Head of Finance & Admin. | 26 Jan 2024 | 13,000 | 12,740 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Richard Scalzo William | SVP, Head of Finance & Admin. | 26 Jan 2024 | 13,000 | 137,228 | - | 1.0 | 13,390 | Common Stock | |
| Dyne Therapeutics Inc | Richard Scalzo William | SVP, Head of Finance & Admin. | 03 Jan 2024 | 13,000 | 137,228 | - | 1.0 | 13,390 | Common Stock | |
| Dyne Therapeutics Inc | Richard Scalzo William | SVP, Head of Finance & Admin. | 03 Jan 2024 | 13,000 | 25,740 | - | - | Stock option (right to buy) | ||
| Dyne Therapeutics Inc | Scalzo William Richard | SVP, Head of Finance & Admin. | 03 Jan 2024 | 13,000 | 124,228 | - | 18.8 | 244,530 | Common Stock | |
| Dyne Therapeutics Inc | William Richard Scalzo | See Remarks | 14 Dec 2023 | 2,376 | 124,228 | - | 12.0 | 28,560 | Common Stock | |
| Dyne Therapeutics Inc | Scalzo William Richard | See Remarks | 11 Dec 2023 | 1,380 | 126,604 | - | 10.7 | 14,794 | Common Stock | |
| Dyne Therapeutics Inc | William Scalzo Richard | See Remarks | 04 Dec 2023 | 1,872 | 127,984 | - | 12.0 | 22,483 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 04 Dec 2023 | 681 | 129,856 | - | 12.0 | 8,179 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 15 Nov 2023 | 89,742 | 130,537 | - | 0 | Common Stock | ||
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 15 Nov 2023 | 34,946 | 34,946 | - | - | Stock Option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 18 Sep 2023 | 1,290 | 40,795 | - | 9.4 | 12,139 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 12 Sep 2023 | 1,397 | 42,085 | - | 10.4 | 14,543 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 13 Jun 2023 | 40,000 | 38,740 | - | - | Stock Option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 13 Jun 2023 | 40,000 | 53,482 | - | 12.9 | 515,600 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 13 Jun 2023 | 40,000 | 93,482 | - | 1.0 | 41,200 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 13 Jun 2023 | 10,000 | 43,482 | - | 12.0 | 120,300 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 13 Jun 2023 | 1,390 | 53,482 | - | 12.4 | 17,278 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 14 Mar 2023 | 1,311 | 54,872 | - | 13.3 | 17,476 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 09 Dec 2022 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 09 Dec 2022 | 31,000 | 56,495 | - | 0 | Common Stock | ||
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 09 Dec 2022 | 312 | 56,183 | - | 10.9 | 3,391 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 20 Sep 2022 | 840 | 25,495 | - | 13.7 | 11,508 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 15 Sep 2022 | 326 | 26,335 | - | 14.0 | 4,580 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 11 Jul 2022 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 05 Jul 2022 | 17,333 | 17,333 | - | - | Stock Option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 14 Jun 2022 | 333 | 26,661 | - | 4.9 | 1,648 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 11 Mar 2022 | 308 | 26,994 | - | 8.7 | 2,689 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 10 Dec 2021 | 25,044 | 25,044 | - | - | Stock Option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 10 Dec 2021 | 16,696 | 27,302 | - | 0 | Common Stock | ||
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 20 Sep 2021 | 492 | 10,606 | - | 16.1 | 7,926 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 20 Sep 2021 | 367 | 11,098 | - | 15.6 | 5,729 | Common Stock | |
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 16 Sep 2020 | 35,575 | 35,575 | - | - | Stock Option (right to buy) | ||
| Dyne Therapeutics Inc | Richard William Scalzo | See Remarks | 16 Sep 2020 | 11,465 | 11,465 | - | 0 | Common Stock |